Nuvectis Pharma Inc Cash Flow Reinvestment Rate

Latest as of December 2020: 0.00x

Nuvectis Pharma Inc cash flow reinvestment rate. Nuvectis Pharma Inc (NVCT) has a Cash Flow Reinvestment Rate of 0.00x as of December 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $24.00K. Explore NVCT operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$24.00K
USD

Capital Expenditures

$0.00
USD

Cash Flow Reinvestment Rate of Nuvectis Pharma Inc (2020–2020)

Cash flow reinvestment rate of Nuvectis Pharma Inc from 2020 to 2020. Historical reinvestment intensity for Nuvectis Pharma Inc across 1 annual periods. Also explore Nuvectis Pharma Inc annual equity growth to track the company's year-over-year net asset growth rate.

Nuvectis Pharma Inc Cash Flow Reinvestment Rate by Year (2020–2020)

Nuvectis Pharma Inc cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for Nuvectis Pharma Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Nuvectis Pharma Inc.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2020 0.00x $0.00 $24.00K $0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow